Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001567619-22-007581
Filing Date
2022-03-28
Accepted
2022-03-28 16:25:26
Documents
1
Effectiveness Date
2022-03-28
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 13298
  Complete submission text file 0001567619-22-007581.txt   14315
Mailing Address 228 PARK AVENUE SOUTH NEW YORK NY 10003
Business Address 228 PARK AVENUE SOUTH NEW YORK NY 10003 805-691-9355
Elucida Oncology, Inc. (Filer) CIK: 0001704594 (see all company filings)

IRS No.: 471358366 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-439279 | Film No.: 22775784